
Market close: NZ shares fall as smelter closure routs energy stocks
The benchmark took a dive on news Rio Tinto planned to close Tiwai Point smelter.
The benchmark took a dive on news Rio Tinto planned to close Tiwai Point smelter.
Shifting excess power north means transmission charges could climb.
Covid-19 has halted construction as well as property settlements.
New offer $169.8m compared with previous $180m offer pre-pandemic
Trustpower will appeal decision to replace the transmission pricing guidelines.
New Zealand shares followed Australia lower.
SkyCity has been rapped on the knuckles for an email sent to customers.
New Zealand shares rose for a fourth day.
The firm expects its earnings in the 12 months through August to face a material hit.
Metlifecare led the benchmark higher.
Focus on becoming high end premium flooring brand rather than strengthening balance sheet.
Metlifecare made a surprise announcement this morning.
Ammonia leak delays seasonal return to work for Fonterra Te Rapa site staff.
When the sugar rush of a post-lockdown rebound ends, we will need to reinvent our economy.
They've struck rocky waters - what does the future hold for those wanting to influence us?
Some investors were encouraged by better-than-expected US jobs data.
The sharemarket has had a great run, but appearances can sometimes be deceptive.
Airlines have 21% more planes in the air this week - the challenge is filling them.
Markets across Asia followed Wall Street higher.
And continuing delays in the release of blockbuster movies aren't helping.
The retailer has detailed strong sales recovery over the past six weeks.
A mid-year tally of progress in the annual Brokers Picks game reveals surprising turns.
New Zealand shares fell on the back of a grim update from Auckland International Airport.
F&P Healthcare has hired some 600 additional direct manufacturing staff locally.
AIA expects to take a $50-$90m ht from Covid-19 costs in its upcoming result.
One of the country's most costly divorces has ended in an agreement.
Investors continued to react to F&P Healthcare's record result yesterday.
Analysts upgrade Stride to various euphemisms of "buy".